文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克急性提升平均动脉压的心血管反应异质性:心室-动脉偶联与静脉回流的作用

Heterogeneous cardiovascular responses to acute mean arterial pressure augmentation in septic shock: the role of ventriculo-arterial coupling and venous return.
PubMed 文献 · Crit Care · 2026-09-09
一句话结论脓毒性休克患者把MAP从约65 mmHg升至85 mmHg后,31%心输出量增加、53%稳定、16%恶化,恶化者心室-动脉偶联变差且左室射血分数下降。

尽管MAP升幅相近,10例(31%)出现流量募集、17例(53%)流量稳定、5例(16%)流量恶化。流量恶化者有效动脉弹性增加而左室收缩末期弹性未成比例增加,导致心室-动脉偶联恶化(ΔEa/Ees +0.22 IQR 0.01-0.81),同时伴LVEF降低及衍生静脉回流指标改变。结果提示MAP提升并不总能改善前向血流,床旁需要识别流量恶化表型。

要点

  • 脓毒性休克患者MAP从约65 mmHg提升至85 mmHg后反应不一:31%流量募集(CO增加>15%)、53%稳定(CO变化±15%)、16%流量恶化(CO降低>15%)。
  • 流量恶化者表现为Ea增加而Ees未成比例增加,心室-动脉偶联恶化,ΔEa/Ees +0.22 IQR 0.01-0.81,而流量保持或增加者偶联稳定或改善(p=0.035)。
  • 流量恶化同时伴LVEF降低及衍生静脉回流指标改变,提示收缩适应受损和前负荷相关因素可能共同参与前向血流下降。
  • ΔEa/Ees与等容收缩时间(IVCT)ρ=0.788、p<0.0001,与心肌性能指数(MPI)ρ=0.599、p<0.0003,与每搏量ρ=-0.418、p=0.017,与LVEFρ=-0.431、p=0.0139相关。
  • 该研究采用去甲肾上腺素加量或根据临床判断加用血管加压素来实现MAP提升,未规定统一药物方案,因此不同药物途径对偶联和回流的影响不能由本研究拆解。

适用人群与场景

  • 机械通气的脓毒性休克成人患者,在初始血流动力学复苏后接受MAP从约65 mmHg急性提升至85 mmHg。
  • 场景为脓毒性休克急性循环管理阶段,床旁有经胸超声心动图评估条件。

诊断标准与关键阈值

  • 流量募集定义为心输出量相对变化>15%增加;稳定流量定义为-15%至+15%;流量恶化定义为>15%降低。
  • 心室-动脉偶联以Ea/Ees比值表示;恶化定义为Ea增加而Ees未成比例增加,原文未给出诊断性截断值。
  • MAP目标为从约65 mmHg提升至85 mmHg;达到相似动脉压力目标后按CO相对变化进行分组。

处置流程与药物剂量

  • 第一步:在初始血流动力学复苏后,将MAP从约65 mmHg急性提升至85 mmHg。
  • 第二步:提升MAP采用去甲肾上腺素剂量递增或加用血管加压素,具体方案根据临床判断选择,原文未给出统一剂量、输注速率或疗程。
  • 第三步:MAP提升前后立即进行经胸超声心动图,测量CO、每搏量、LVEF、Ea、Ees、Ea/Ees、IVCT、MPI、Pmsa及衍生静脉回流指标。
  • 第四步:根据CO相对变化识别流量募集、稳定或恶化,其中流量恶化者需关注Ea/Ees恶化、每搏量和LVEF下降及衍生静脉回流指标改变。
  • 原文未给出针对流量恶化表型应如何调整血管活性药、正性肌力药、液体或MAP目标值的具体治疗建议。

红旗征与不能漏的情况

  • MAP提升后CO降低>15%即流量恶化,本研究中见于16%的患者,提示升压不能改善甚至可能损害前向血流。
  • 流量恶化者出现Ea/Ees增加、LVEF下降和每搏量下降,提示心室对后负荷增加的收缩适应失代偿,应警惕继续追求更高MAP可能加重心功能障碍。
  • ΔEa/Ees与IVCT和MPI呈较强正相关,提示心室-动脉偶联恶化伴随收缩不同步或心肌性能恶化,需床旁结合超声识别而非仅看血压。

研究设计与关键结果

  • 干预为MAP从约65 mmHg急性提升至85 mmHg,途径为增加去甲肾上腺素或加用血管加压素,根据临床判断选择。
  • 主要分组结果为31%流量募集、53%稳定、16%恶化;各组MAP升幅相近但CO反应不同。
  • 流量恶化组ΔEa/Ees为+0.22 IQR 0.01-0.81,与流量保持或增加组比较p=0.035;ΔEa/Ees与IVCTρ=0.788、p<0.0001,与MPIρ=0.599、p<0.0003。
  • ΔEa/Ees与每搏量ρ=-0.418、p=0.017,与LVEFρ=-0.431、p=0.0139;流量恶化还与LVEF降低和衍生静脉回流指标改变相关。

证据类型、等级与局限

  • 证据类型为前瞻性生理观察研究,非随机对照,非干预性疗效研究。

对床旁实践的改变

  • 在脓毒性休克患者提升MAP时,不应默认心输出量会随血压升高而改善;本研究中约16%出现流量恶化,提示需要用超声或血流动力学监测重新评估继续升压的获益。
  • 床旁可通过CO相对变化(>15%增加、±15%稳定、>15%降低)判断患者属于流量募集、稳定还是恶化表型,但该分类为研究分组,原文未给出决策阈值或启动干预标准。
  • 流量恶化患者可能伴心室-动脉偶联恶化、LVEF及每搏量降低和静脉回流指标改变,对这类患者继续单纯提高后负荷需警惕,但原文未给出应换用或停用何种药物。
  • 本研究不能说明常规MAP 65 mmHg优于85 mmHg,也不能说明何种血管加压素更安全;其价值在于提示MAP目标应个体化并结合血流动力学反应评估。
  • 适用场景为有床旁超声能力的ICU或重症监护单元;原文未给出不适用人群。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: In patients with septic shock, vasopressor-induced mean arterial pressure (MAP) augmentation is commonly used to restore tissue perfusion; however, patients may exhibit divergent cardiovascular responses despite achieving similar arterial pressure targets. We hypothesized that this heterogeneity reflects the differences in ventricular adaptation to increases in arterial load and venous return determinants.

METHODS: We conducted a prospective physiological observational study in mechanically ventilated adults with septic shock who underwent transient MAP augmentation from approximately 65 to 85 mmHg after the initial hemodynamic resuscitation. MAP was increased by norepinephrine dose escalation or by adding vasopressin according to clinical judgment. Comprehensive transthoracic echocardiography was performed immediately before and after MAP augmentation. Patients were classified a priori according to the relative changes in cardiac output (CO): flow recruitment (> 15% increase), stable flow (- 15% to + 15%), or flow deterioration (> 15% decrease). Changes in effective arterial elastance (Ea), end-systolic elastance (Ees), VA coupling (Ea/Ees), stroke volume, left ventricular ejection fraction (LVEF), analogue mean systemic filling pressure (Pmsa), and derived venous return variables were analyzed.

RESULTS: Thirty-two patients were included. Despite comparable increases in MAP, the cardiovascular responses were heterogeneous: 10 patients (31%) exhibited flow recruitment, 17 (53%) maintained a stable flow, and 5 (16%) developed flow deterioration. Patients with flow deterioration showed a greater increase in Ea without a proportional increase in Ees, resulting in worsening VA coupling (ΔEa/Ees + 0.22 IQR [0.01-0.81]), whereas VA coupling remained stable or improved in patients with preserved or increased flow (p = 0.035). Flow deterioration was also associated with reduced LVEF and changes in the derived venous return indices, which may have contributed to the observed reduction in forward flow. Changes in VA coupling correlated with changes in IVCT (ρ = 0.788, p < 0.0001), MPI (ρ = 0.599, p < 0.0003), stroke volume (ρ =-0.418, p = 0.017), and LVEF (ρ=-0.431, p = 0.0139).

CONCLUSIONS: Acute MAP augmentation elicits heterogeneous cardiovascular responses in patients with septic shock despite similar increases in arterial pressure. Flow deterioration is characterized by worsening VA coupling, reduced stroke volume, and impaired systolic adaptation, potentially modulated by changes in the derived venous return indices.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Valenzuela, Mercado, Medel, et al. Heterogeneous cardiovascular responses to acute mean arterial pressure augmentation in septic shock: the role of ventriculo-arterial coupling and venous return. Crit Care. 2026. PMID: 42934779. doi:10.1186/s13054-026-06317-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。